Skip Navigation


Radiation Protection Dosimetry Advance Access originally published online on March 19, 2009
Radiation Protection Dosimetry 2009 133(3):165-170; doi:10.1093/rpd/ncp034
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
133/3/165    most recent
ncp034v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Karaçam, S. C.
Right arrow Articles by Bese, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karaçam, S. C.
Right arrow Articles by Bese, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The investigation of fetal doses in mantle field irradiation

Songül Çavdar Karaçam1,*, Onur Sahin Güralp2, Didem Çolpan Öksüz1, Ayse Koca3, Ismail Çepni2, Kimia Çepni4 and Nuran Bese1

1 Department of Radiation Oncology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
2 Department of Obstetrics and Gynecology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
3 Private Sante Hospital, Istanbul, Turkey
4 Department of Radiation Oncology, Okmeydani Education and Research Hospital, Istanbul, Turkey

* Corresponding author: songulkaracam{at}yahoo.com

Received November 7, 2008, amended February 11, 2009, accepted February 19, 2009

To determine clinically the fetal dose from irradiation of Hodgkin's disease during pregnancy and to quantify the components of fetal dose using phantom measurements. The fetal dose was measured with phantom measurements using thermoluminescent dosemeters (TLDs). Phantom measurements were performed by simulating the treatment conditions on an anthropomorphic phantom. TLDs were placed on the phantom 41, 44, 46.5 and 49.5 cm from the centre of the treatment field. Two TLDs were placed on the surface of the phantom. The estimated total dose to all the TLDs ranged from 8.8 to 13.2 cGy for treatment with 60Co and from 8.2 to 11.8 cGy for 4 MV photons. It was concluded that the doses in different sections were evaluated to investigate dose changes in different points and depths of fetal tissues in phantom. Precise planning and the use of supplemental fetal shielding may help reduce fetal exposure.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.